[1]
S. Ariyawongsakul, winyoo jantrasoontragul, R. Tiratuntayaporn, and C. Nijwattana, “A Proof-of-Concept Study for an Intradermal Dose-Sparing Strategy: Non-Inferior Immunogenicity and Improved Systemic Tolerability of Fractional-Dose ChAdOx1-S SARS-CoV-2 Vaccine Compared to Intramuscular Administration”, rtafmg, vol. 71, no. 2, pp. 106–117, Dec. 2025.